RePORT International Highlights

SUBMISSION PERIOD: 9 April - 16 May, 2026 The late-breaker abstract submission will be open from 9 April to 6 May 2026. Late-breaker submissions must introduce data of unquestioned significance that meet a high threshold of scientific merit. During abstract submission, authors will have to justify why their abstract should be considered as a late breaker. The same submission rules apply for late-breaker abstracts as for regular abstracts, but each presenting author may present only one late-breaker abstract at the conference. The percentage of abstracts selected as late breakers will depend on the number of submissions, but selection will be far more rigorous than for regular abstracts.

Advancing Military and Civilian Medical Research Including Military Infectious Diseases Research Program Closing Date: Sep 30, 2027

CONFERENCE DATE: 22-25 February, 2026; LOCATION: Denver, Colorado, USA The Conference on Retroviruses and Opportunistic Infections (CROI) was established in 1993 to provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases. The synergy of basic science and clinical investigation has been a major contributor to the success of the meeting. CROI has facilitated the presentation of important discoveries in the field, thereby accelerating progress in HIV and AIDS research. CROI highlights the latest research in HIV, hepatitis viruses, SARS-CoV-2 (including long COVID), mpox, and their related conditions.

The Conference on Retroviruses and Opportunistic Infections (CROI) was established in 1993 to provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases. The synergy of basic science and clinical investigation has been a major contributor to the success of the meeting. CROI has facilitated the presentation of important discoveries in the field, thereby accelerating progress in HIV and AIDS research. CROI highlights the latest research in HIV, hepatitis viruses, SARS-CoV-2 (including long COVID), mpox, and their related conditions. Abstracts are evaluated by the Scientific Program Committee and additional reviewers for the relevance of their topics, the rigor of their research, and the distinct contributions they make to the broad spectrum of study that CROI strives to provide each year. Attendance at the conference is open to researchers and clinical educators actively involved in the study and management of HIV, other retroviruses, and related medical conditions. Limited space is also available to members of the media whose work aligns with the scientific and educational aims of the conference. The 32nd CROI, held from February 22 to 25, 2026, is planned as an in-person conference in Denver, Colarado, USA.

E.W. "Al" Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States. Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority.​

APPLICATION DEADLINE: 9 March, 2026 The International Research Scientist Development Award (IRSDA) provides support and protected time (three to five years) to advanced postdoctoral U.S. research scientists and recently-appointed U.S. junior faculty (applicants must be at least two years beyond conferral of doctoral degree) for an intensive, mentored research career development experience. The experience will be in a low- or middle-income country (LMIC) as defined by the World Bank . Low-income, lower-middle-income and upper-middle-income countries are included. Applications are invited from early career investigators from any health-related discipline who propose career development activities and a research project that is related to the health priorities of the LMIC.

Global Health EDCTP3 has launched its 2026 Work Programme, which includes six calls for proposals to support research and innovation projects addressing tuberculosis, lower respiratory tract infections, HIV, climate-change-driven infectious diseases and other pressing global health challenges. The calls for proposals will open for submission by mid-January 2026. To support interested applicants, an online Info Day will be held on 5 February 2026. During the event, participants will receive detailed information on the call topics, application process and evaluation criteria. Please refer to the webiste for the key dates and details.

MULTIPLE DEADLINES Please refer to the website for the details Global Health EDCTP3 invests in global health through funding collaborative research and innovation projects tackling infectious diseases and supporting activities for research capacity building in Africa. Check the website for detailed information on the calls for proposals.

Deadline: March 26, 2026 HFSP Research Grants support innovative basic research into fundamental biological problems with emphasis placed on novel and interdisciplinary approaches that involve scientific exchanges across national and disciplinary boundaries. Two types of Grant are available: Research Grants – Early Career and Research Grants – Program. Award amounts vary.

FULL PROPOSAL SUBMISSION DEADLINE: 21 April 2026 at 17:00 Brussels time IHI call 12 is a single-stage, applicant-driven call with topics aligned with the specific objectives of the IHI Strategic Research and Innovation Agenda. The call contains five topics, each focusing on one of the five IHI Specific Objectives (SOs) as set out in the Strategic Research and Innovation Agenda (SRIA): Topic 1 (SO1): Boosting innovation for a better understanding of the determinants of health Topic 2 (SO2): Boosting innovation through better integration of fragmented health R&I efforts Topic 3 (SO3): Boosting innovation for people-centred integrated healthcare solutions Topic 4 (SO4): Boosting innovation through exploitation of digitalisation and data exchange in healthcare Topic 5 (SO5): Boosting innovation for better assessment of the added value of innovative integrated healthcare solutions For full details of the topics, including the budget breakdown, read the call text. All documents relating to the call can be found via the Funding and Tenders Portal and the IHI call documents page. We advise you to read these documents, in particular the guide for applicants, carefully.

CONFERENCE DATE: 26-31 July 2026; LOCATION: Rio de Janeiro, Brazil and virtually Please refer to the website for the details.

CONFERENCE DATE: 12-15 May 2026; LOCATION: Dar es Salaam, Tanzania The annual INTEREST Conference is the premier scientific conference for HIV in Africa and brings together scientists involved in HIV treatment, pathogenesis, and prevention research from around the world. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection. Additionally, it will continue to foster building a community of African physicians and scientists to facilitate the implementation of local solutions for the management of patients living with HIV-1 infection and for the prevention of HIV transmission. The programme will consist of invited lectures, oral abstract presentations, a debate, skill-building sessions, panel discussions, and sponsored symposia.

The JHU TRAC has partnered with RePORT International to offer Hopkins affiliates and their mentees the opportunity to enroll in JHU CANVAS asynchronous TB research courses. Select from the following courses: Epidemiology for TB Professional Development: Starting and Building Your Research Career Immunology for TB Introduction to Data Visualization Introduction to R Programming

Poster Abstract Deadline: 2 March, 2026 Early Registration Deadline: 22 January, 2026 The meeting will engage and feature the next generation of TB researchers to drive the field forward and foster cross-disciplinary insights and collaborations. TB mostly affects the Global South, but its research is poorly represented in scientific meetings. In contrast, early-career researchers from the Global South will be enabled to exchange ideas and discuss approaches and resources that are needed for future research with leading experts in the TB field. Please refer to the webiste for the key dates and details.

Please refer to the website for the details on deadline, pricing, courses that are offered

The Work Programme 2026 has been revised to include a new funding scheme, ERC Plus Grants, which will support outstanding researchers from Europe and anywhere in the world with bold ideas and a vision for transformative research that goes beyond the scope of existing ERC programmes.

A consolidated listing of forms, format pages, and instructions grouped by their use.

The material in this series will increase your awareness of work, communication, and conflict styles, using examples highly relevant to research environments. The series is helpful for trainees and fellows at all levels. The series is also helpful for fellows who supervise others and want to develop strong mentoring skills for the future. There are three sessions in the series; each is offered once in the fall and spring. While it is best to attend the entire series, you may attend individual sessions. Trainees and fellows who complete all three units of the Workplace Dynamics Series will receive a certificate of completion. All three units of this series are required for participation in the OITE Management Short Course offered each spring.

By accepting a grant award, recipients agree to comply with the requirements in the NIH Grants Policy Statement unless the notice of award states otherwise. Please refer to the website for specific policy topic pages for additional context and resources.

To advance science and improve human health, NIH makes the peer-reviewed articles it funds publicly available on PubMed Central. The 2024 NIH Public Access Policy requires Author Accepted Manuscripts accepted for publication in a journal, on or after July 1, 2025, to be submitted to PubMed Central upon acceptance for publication, for public availability without embargo upon the Official Date of Publication